or Try an Advanced Search...

    Technical Analysis for CTLT - Catalent, Inc.

    Grade Last Price % Change Price Change
    B 56.16 -0.12% -0.07
    CTLT closed down 0.12 percent on Monday, July 1, 2024, on 72 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Flat
    Historical CTLT trend table...
    Date Alert Name Type % Chg
    Shooting Star Candlestick Bearish 0.00%
    Calm After Storm Range Contraction -0.12%
    180 Bullish Setup Bullish Swing Setup 0.00%
    Calm After Storm Range Contraction 0.00%
    Calm After Storm Range Contraction 0.04%
    Stochastic Reached Overbought Strength 0.04%
    Overbought Stochastic Strength 0.04%
    Calm After Storm Range Contraction -0.55%
    Gilligan's Island Sell Setup Bearish Swing Setup -0.60%
    Crossed Above 20 DMA Bullish -0.60%
    Older End-of-Day Signals for CTLT ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 10 hours ago
    60 Minute Opening Range Breakdown 3 days ago
    1.5x Volume Pace 3 days ago
    Rose Above Previous Day's High 3 days ago
    Bullish 180 Entry 4 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CTLT Chart by TradingView
    Basic chart:

    Profile

    Catalent, Inc. Description

    Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment provides advanced oral delivery technologies, including formulation, development, and manufacturing of oral dose forms for prescription and consumer health products. This segment's oral dose forms include softgel, modified release technologies, and immediate release solid oral products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also offers analytical chemical and cell-based testing and scientific services, stability testing, respiratory products formulation and manufacturing, regulatory consulting, and bioanalytical testing for biologic products. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.

    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: S&P 500 Biotechnology Biopharmaceutical Life Sciences Pharmacy Pharmacology Health Products Ophthalmic Inventory Management Clinical Services Logic Products Biologic Products Oral Products Biologic Product Respiratory Products Catalent Consumer Health Products Inventory Management Services Softgel

    Is CTLT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 25 Beyond Elevidys: Unveiling The Competitive Landscape Of Duchenne's Muscular Dystrophy
    Jun 21 Catalent gains after Sarepta's Elevidys gets label expansion
    Jun 7 Why Is Catalent (CTLT) Up 0.4% Since Last Earnings Report?
    May 30 Catalent (NYSE:CTLT) investors are sitting on a loss of 47% if they invested three years ago
    May 29 Catalent shareholders approve acquisition by Novo Holdings
    May 29 Catalent Stockholders Approve Transaction with Novo Holdings
    May 13 Catalent's (CTLT) Latest Partnership to Boost Clinical Trials
    May 9 Catalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up
    May 9 Decoding Catalent Inc (CTLT): A Strategic SWOT Insight
    May 8 Catalent (CTLT) Reports Q3 Loss, Misses Revenue Estimates
    See more CTLT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 60.2
    52 Week Low 31.8001
    Average Volume 1,699,481
    200-Day Moving Average 49.92
    50-Day Moving Average 55.60
    20-Day Moving Average 55.79
    10-Day Moving Average 55.92
    Average True Range 0.62
    RSI (14) 55.56
    ADX 16.86
    +DI 24.47
    -DI 18.98
    Chandelier Exit (Long, 3 ATRs) 54.95
    Chandelier Exit (Short, 3 ATRs) 55.40
    Upper Bollinger Bands 57.03
    Lower Bollinger Band 54.56
    Percent B (%b) 0.65
    BandWidth 4.44
    MACD Line 0.23
    MACD Signal Line 0.15
    MACD Histogram 0.081
    Fundamentals Value
    Market Cap 10.15 Billion
    Num Shares 181 Million
    EPS -7.18
    Price-to-Earnings (P/E) Ratio -7.82
    Price-to-Sales 2.50
    Price-to-Book 2.78
    PEG Ratio 3.77
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 57.03
    Resistance 3 (R3) 57.10 56.87 56.89
    Resistance 2 (R2) 56.87 56.65 56.84 56.84
    Resistance 1 (R1) 56.52 56.51 56.41 56.45 56.79
    Pivot Point 56.29 56.29 56.24 56.26 56.29
    Support 1 (S1) 55.94 56.07 55.83 55.87 55.53
    Support 2 (S2) 55.71 55.93 55.68 55.48
    Support 3 (S3) 55.36 55.71 55.44
    Support 4 (S4) 55.29